They don't, they're not going to do that part
BPC-157 research has extensively documented mucosal healing and cytoprotection [7], while KPV studies demonstrated significant reduction of colitis severity in multiple rodent models[8]: BPC-157 component: Healing acceleration in NSAID-induced gastric ulcers and stress-induced damage KPV component: Reduced inflammatory cell infiltration and lower MPO activity in DSS-induced colitis Combined potential: Addresses both tissue damage and inflammatory pathways simultaneously Fistula healing demonstrated in BPC-157 studies with potential inflammatory control from KPV PepT1-mediated KPV uptake enables targeted delivery to inflamed intestinal tissues Research on individual components suggests the combination may provide superior outcomes by healing damaged tissue while actively suppressing inflammatory cascades that impair repair[9]
In addition, the intervention process and its technical difficulty level were documented (ERCP degree of difficulty grades)
, 6 , 679-684, Vilkaitis, G., Maseviius, V., Kriukien, E., and Klimaauskas, S
